- Home
- Publications
- Publication Search
- Publication Details
Title
Secondary malignancies among mantle cell lymphoma patients
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume -, Issue -, Pages 113403
Publisher
Elsevier BV
Online
2023-10-29
DOI
10.1016/j.ejca.2023.113403
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long term follow-up of Rituximab plus Bendamustine and Cytarabine (R-BAC) in elderly patients with newly diagnosed MCL
- (2023) Maria Chiara Tisi et al. Blood Advances
- Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
- (2022) Joel Kristinn Joelsson et al. Blood Advances
- Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
- (2022) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
- (2022) Youxi Yu et al. Cell and Bioscience
- Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
- (2021) Jonas F Ludvigsson et al. Clinical Epidemiology
- Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance after First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the MCL R2 Elderly Clinical Trial
- (2021) Vincent Ribrag et al. BLOOD
- Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
- (2020) Jin Seok Kim et al. Cancer Research and Treatment
- Second primary cancers in non‐Hodgkin lymphoma: Family history and survival
- (2019) Subhayan Chattopadhyay et al. INTERNATIONAL JOURNAL OF CANCER
- Triangle: Autologous Transplantation after a Rituximab/Ibrutinib/ara-c Containing Induction in Generalized Mantle Cell Lymphoma - a Randomized European MCL Network Trial
- (2019) Martin Dreyling et al. BLOOD
- Comorbidities and sex differences in causes of death among mantle cell lymphoma patients – A nationwide population‐based cohort study
- (2019) Ingrid Glimelius et al. BRITISH JOURNAL OF HAEMATOLOGY
- A systematic comparison of recurrent event models for application to composite endpoints
- (2018) Ann-Kathrin Ozga et al. BMC Medical Research Methodology
- Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety
- (2018) Wolfgang Hiddemann et al. JOURNAL OF CLINICAL ONCOLOGY
- Frontline Treatment for Older Patients with Mantle Cell Lymphoma
- (2018) Haige Ye et al. ONCOLOGIST
- Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow-up from a pooled analysis
- (2018) Simon Rule et al. HAEMATOLOGICA
- Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma
- (2017) Apurvasena Parikh et al. LEUKEMIA & LYMPHOMA
- Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
- (2016) A. Albertsson-Lindblad et al. BLOOD
- Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis
- (2015) I. Fleury et al. ANNALS OF ONCOLOGY
- Modelling recurrent events: a tutorial for analysis in epidemiology
- (2014) Leila DAF Amorim et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
- (2013) Lois B. Travis et al. Nature Reviews Clinical Oncology
- Dose Dependent Effects on Cell Cycle Checkpoints and DNA Repair by Bendamustine
- (2012) Neil Beeharry et al. PLoS One
- Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry
- (2011) Anna Abrahamsson et al. LEUKEMIA & LYMPHOMA
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
- (2007) E. Hoster et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started